Basic Drug Info
Drug Name:Lotrisone
Manufacturer:Schering Corporation
Other Info:

Rx onlySchering CorporationKenilworth, NJ 07033 USACopyright © 2000, 2007, Schering Corporation.

All rights reserved.Rev.


Clinical Trials:

Indications and Usage

LOTRISONE® Cream and Lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum.

Effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections.

The efficacy of LOTRISONE Cream or Lotion for the treatment of infections caused by zoophilic dermatophytes (eg, Microsporum canis) has not been established.

Several cases of treatment failure of LOTRISONE Cream in the treatment of infections caused by Microsporum canis have been reported.
TINEA PEDIS -- Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.


Tinea corporis (disorder) --

Tinea -- A general term describing various dermatophytoses. Specific types include TINEA CAPITIS (ringworm of the scalp), TINEA FAVOSA (of scalp and skin), TINEA PEDIS (athlete's foot), and tinea unguium (see ONYCHOMYCOSIS, ringworm of the nails). (Dorland, 27th ed)

Infection -- Invasion of the host organism by microorganisms that can cause pathological conditions or diseases.

LOTRISONE® Cream or Lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or imidazoles, or to any ingredient in these preparations.

This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.